Resource Type

Journal Article 5

Year

2021 1

2018 2

2015 2

Keywords

O-glycosylation 1

B cells 1

CLEC-2 1

Id proteins 1

Prox1 1

T cells 1

TGF-β 1

Zfyve16 1

allogeneic hematopoietic stem cell transplantation 1

bone marrow infiltration 1

clonal T-cell population 1

endofin 1

hematopoiesis 1

leukemia 1

lymphatic vascular development and maintenance 1

lymphocytes 1

lymphoid malignancies 1

lymphoid organ homeostasis 1

lymphoma 1

mature T-cell lymphoid malignancies 1

open ︾

Search scope:

排序: Display mode:

Paradoxical role of Id proteins in regulating tumorigenic potential of lymphoid cells

Sumedha Roy, Yuan Zhuang

Frontiers of Medicine 2018, Volume 12, Issue 4,   Pages 374-386 doi: 10.1007/s11684-018-0652-x

Abstract:

A family of transcription factors known as Id proteins, or inhibitor of DNA binding and differentiation, is capable of regulating cell proliferation, survival and differentiation, and is often upregulated in multiple types of tumors. Due to their ability to promote self-renewal, Id proteins have been considered as oncogenes, and potential therapeutic targets in cancer models. On the contrary, certain Id proteins are reported to act as tumor suppressors in the development of Burkitt’s lymphoma in humans, and hepatosplenic and innate-like T cell lymphomas in mice. The contexts and mechanisms by which Id proteins can serve in such contradictory roles to determine tumor outcomes are still not well understood. In this review, we explore the roles of Id proteins in lymphocyte development and tumorigenesis, particularly with respect to inhibition of their canonical DNA binding partners known as E proteins. Transcriptional regulation by E proteins, and their antagonism by Id proteins, act as gatekeepers to ensure appropriate lymphocyte development at key checkpoints. We re-examine the derailment of these regulatory mechanisms in lymphocytes that facilitate tumor development. These mechanistic insights can allow better appreciation of the context-dependent roles of Id proteins in cancers and improve considerations for therapy.

Keywords: Id proteins     lymphoma     leukemia     T cells     B cells     tumor suppressor     oncogene    

Clinical characteristics and prognostic factors of patients with mature T-cell lymphoid malignancies:

Wen Xue,Yan Sheng,Xiangqin Weng,Yongmei Zhu,Yan Zhao,Pengpeng Xu,Xiaochun Fei,Xiaoyan Chen,Li Wang,Weili Zhao

Frontiers of Medicine 2015, Volume 9, Issue 4,   Pages 468-477 doi: 10.1007/s11684-015-0419-6

Abstract:

Mature T-cell lymphoid malignancies comprise a group of heterogeneous diseases that vary in clinicopathologicalBone marrow (BM) infiltration is more commonly present in mature T-cell lymphoid malignancies comparedstudy, clinical characteristics and prognostic factors were analyzed in 225 patients with mature T-cell lymphoidclinical characteristics may be useful in more effectively stratifying patients with mature T-cell lymphoid

Keywords: mature T-cell lymphoid malignancies     clonal T-cell population     bone marrow infiltration     prognostic factors    

post-transplantation cyclophosphamide for allogeneic peripheral stem cell transplantation for adult patients with lymphoid

Ling Wang, Lining Wang, Xing Fan, Wei Tang, Jiong Hu

Frontiers of Medicine 2021, Volume 15, Issue 1,   Pages 108-115 doi: 10.1007/s11684-019-0730-8

Abstract: Improved survival rate was reported in lymphoid malignancies following PT-Cy strategy compared with myeloidprophylaxis after myeloablative conditioning and T cell-replete peripheral stem cell transplantation in lymphoidA prospective study with additional patients is warranted to confirm the role of PT-Cy in lymphoid malignancy

Keywords: post-transplantation cyclophosphamide     allogeneic hematopoietic stem cell transplantation     lymphoid malignancies    

Zfyve16 regulates the proliferation of B-lymphoid cells

Xuemei Zhao, Donghe Li, Qingsong Qiu, Bo Jiao, Ruihong Zhang, Ping Liu, Ruibao Ren

Frontiers of Medicine 2018, Volume 12, Issue 5,   Pages 559-565 doi: 10.1007/s11684-017-0562-3

Abstract: The proliferation potential of Zfyve16KO B-lymphoid cells also significantlyproliferation of T cells, possibly through the TGF-β signaling, but upregulates the proliferation of B-lymphoid

Keywords: Zfyve16     endofin     hematopoiesis     TGF-β     lymphocytes    

Emerging roles of podoplanin in vascular development and homeostasis

Yanfang Pan,Lijun Xia

Frontiers of Medicine 2015, Volume 9, Issue 4,   Pages 421-430 doi: 10.1007/s11684-015-0424-9

Abstract: This review provides a comprehensive overview of the roles of PDPN in vascular development and lymphoid

Keywords: podoplanin     CLEC-2     Prox1     O-glycosylation     lymphatic vascular development and maintenance     lymphoid    

Title Author Date Type Operation

Paradoxical role of Id proteins in regulating tumorigenic potential of lymphoid cells

Sumedha Roy, Yuan Zhuang

Journal Article

Clinical characteristics and prognostic factors of patients with mature T-cell lymphoid malignancies:

Wen Xue,Yan Sheng,Xiangqin Weng,Yongmei Zhu,Yan Zhao,Pengpeng Xu,Xiaochun Fei,Xiaoyan Chen,Li Wang,Weili Zhao

Journal Article

post-transplantation cyclophosphamide for allogeneic peripheral stem cell transplantation for adult patients with lymphoid

Ling Wang, Lining Wang, Xing Fan, Wei Tang, Jiong Hu

Journal Article

Zfyve16 regulates the proliferation of B-lymphoid cells

Xuemei Zhao, Donghe Li, Qingsong Qiu, Bo Jiao, Ruihong Zhang, Ping Liu, Ruibao Ren

Journal Article

Emerging roles of podoplanin in vascular development and homeostasis

Yanfang Pan,Lijun Xia

Journal Article